TBWA wins three global Merck brands

Share this article:

Merck KGaA has tapped TBWA on three of its consumer healthcare brands: Nasivin, Femibion and Flexagil.

TBWA will handle global communication strategies for each of the brands. The campaigns will debut globally in 2009, according to a company statement.

Neither company responded to inquiries about the assignment. In the statement, Hubertus von Lobenstein, CEO TBWA\Group Germany, said of the wins: “It shows the value of a great team, the international experience as well as the power of our fundamental idea: Disruption.”

Merck's global operating activities function under the umbrella Merck KGaA of Germany, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%, according to the statement. Merck & Co., the US subsidiary, became an independent company in 1917.

Share this article:

Email Newsletters

More in News

Astellas, DOJ settle for $7.3M

Astellas, DOJ settle for $7.3M

Astellas has settled a False Claims case with the Department of Justice over the 2010-2013 marketing of an antifungal medication. Astellas denies the allegations.

Boehringer drug lands US, EU orphan tag

Boehringer drug lands US, EU orphan tag

The experimental Breakthrough Therapy treatment is for acute myeloid leukemia.

Omnio app moves to smartphones

Omnio app moves to smartphones

Physicians Interactive is introducing the third wave of its Omnio app, making the tablet-only tool available for iPhones and Android phones.